Location History:
- Jiangsu, CN (2015)
- Jaingsu, CN (2020)
- Shanghai, CN (2020 - 2023)
Company Filing History:
5 out of 11 
2 out of 5 
1 out of 832,843 Years Active: 2015-2023
Title: An Insight into the Innovations of Inventor Suixiong Cai
Introduction: Suixiong Cai, a prominent inventor based in Shanghai, China, has made remarkable contributions to the field of medicinal chemistry. With a portfolio of 8 patents to his name, Cai's innovative research focuses on developing compounds that hold potential for treating serious clinical conditions, particularly cancer.
Latest Patents: Among Suixiong Cai's latest patents are two notable innovations. The first is centered around **substituted fused heteroaromatic tricyclic compounds as kinase inhibitors**. This patent discloses compounds of the specific Formula I, which may include a pharmaceutically acceptable salt or prodrug. These compounds serve as ATM kinase inhibitors, making them valuable for treating clinical conditions caused by defects in DNA damage repair (DDR) functions, including cancer.
The second patent concerns **imidazo[1,2-b]pyrimido[4,5-d]pyridazin-5(6H)-ones and their applications**. This invention presents compounds also represented by Formula I, designed to act as Wee1 kinase inhibitors. The implications of these compounds are significant as they can be utilized to address diseases linked to abnormal Wee1 activity, showcasing Cai’s commitment to advancing cancer treatment.
Career Highlights: Suixiong Cai has worked with notable companies, such as Impact Therapeutics, Inc. and Impact Therapeutics (Shanghai), Inc., where he has contributed significantly to innovative research in the field. His role in these organizations has been integral to the development of his groundbreaking patented compounds.
Collaborations: Throughout his career, Suixiong Cai has collaborated with various experts, including his coworkers Ye Edward Tian and Xiaozhu Wang. These collaborations have likely fostered an environment of creativity and innovation, contributing to the successful development of his patents.
Conclusion: Suixiong Cai's impactful work in the realm of kinase inhibitors exemplifies the critical intersection of innovative research and practical application in drug development. His patents not only reflect his dedication to addressing pressing health issues such as cancer but also underscore the importance of collaboration within the scientific community. As he continues to build upon his legacy of inventions, the future holds great promise for further advancements in the field.